|
Report: PIP Case Highlights MHRA’s Need for More, Better Medical Device Data
While judging the Medicines and Healthcare products Regulatory Agency’s (MHRA) response to the PIP silicone breast implant scandal basically sound, a new review by the UK Department of Health (DOH) finds the agency needs better access to information on devices to preclude similar safety scares in the future.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives